Figure 5.
Platelet VWF levels are significantly reduced in patients with low VWF. Following platelet lysis, platelet VWF:Ag (A) and platelet VWF:CB levels (B) were determined in 54 patients with low VWF levels. (A) Platelet VWF:Ag was significantly reduced in LoVIC patients (n = 54, triangles) compared with controls (n = 22, circles) (mean values 0.16 vs 0.21 IU/109 platelets; *P < .05). (B) Platelet VWF:CB levels were also significantly reduced in LoVIC patients (triangles) compared with controls (circles) (mean values 0.19 vs 0.34 IU/109 platelets; P < .0001). (C) On the basis of platelet VWF:Ag and platelet VWF:CB levels, patients with low VWF levels were subdivided into 3 distinct groups of “platelet-low” (green box), “platelet-normal” (red box), and “platelet-discordant” (blue box). LoVIC patients are indicated as filled circles and healthy controls as open circles.

Platelet VWF levels are significantly reduced in patients with low VWF. Following platelet lysis, platelet VWF:Ag (A) and platelet VWF:CB levels (B) were determined in 54 patients with low VWF levels. (A) Platelet VWF:Ag was significantly reduced in LoVIC patients (n = 54, triangles) compared with controls (n = 22, circles) (mean values 0.16 vs 0.21 IU/109 platelets; *P < .05). (B) Platelet VWF:CB levels were also significantly reduced in LoVIC patients (triangles) compared with controls (circles) (mean values 0.19 vs 0.34 IU/109 platelets; P < .0001). (C) On the basis of platelet VWF:Ag and platelet VWF:CB levels, patients with low VWF levels were subdivided into 3 distinct groups of “platelet-low” (green box), “platelet-normal” (red box), and “platelet-discordant” (blue box). LoVIC patients are indicated as filled circles and healthy controls as open circles.

Close Modal

or Create an Account

Close Modal
Close Modal